Başyiğit Funda, Yücel Emine Cansu, Uçar Oğuz, Turan Nazlı, Yaman Belma, Akgün Arzu Neslihan, Balcı Mustafa Mücahit, Tolunay Hatice
Department of Cardiology, Ankara Etlik City Hospital, Halil Sezai Erkut Street, Number: 5, 06170, Yenimahalle Ankara, Turkey.
Thromb J. 2025 Jul 1;23(1):72. doi: 10.1186/s12959-025-00751-7.
Recent studies have shown a relation between red blood cell distribution width (RDW) / albumin (RAR) levels and worse outcomes in cases of pulmonary embolism (PE). Simplified pulmonary embolism severity index (sPESI) has been developed from more complex PESI score, predicting the risk of death in patients with acute PE (APE). This study aims to investigate whether RDW-Standard Deviation/Albumin (RDW-SD/Alb) can serve as a useful prognostic marker for APE and enhance the predictive capability of the sPESI.
This research is a single-center, retrospective analysis involving patients over 18 years. We enrolled 235 consecutive hospitalized patients with confirmed APE diagnoses. To evaluate the sensitivity and specificity of RDW-SD/Alb, sPESI, and the combined sPESI plus RDW-SD/Alb in predicting 6-month all-cause death, we used Receiver Operating Characteristic (ROC) curves. Additionally, we conducted Kaplan-Meier analysis to assess the impact of elevated RDW-SD/Alb levels (> 13.6) on patient survival time. We utilized multivariate Cox regression analysis to identify independent prognostic factors affecting patients survival.
The mortality rate for RDW-SD/Alb > 13.6 group was significantly higher than that for the RDW-SD/Alb ≤ 13.6 group. Area under ROC (AUROC) of sPESI plus RDW-SD/Alb was statistically larger than AUROC of sPESI (p = 0.025). In the fully adjusted model, increased RDW-SD/Alb levels were consistently linked to all-cause mortality within six months of admission.
The predictive value of the sPESI for 6-month all-cause death improved when the RDW-SD/Alb > 13.6 parameter was included. RDW-SD/Alb, a novel inflammatory marker, was an independent prognostic factor for predicting 6-month all-cause mortality in patients with APE.
最近的研究表明,红细胞分布宽度(RDW)/白蛋白(RAR)水平与肺栓塞(PE)患者预后较差有关。简化肺栓塞严重程度指数(sPESI)由更复杂的PESI评分发展而来,用于预测急性肺栓塞(APE)患者的死亡风险。本研究旨在探讨RDW标准差/白蛋白(RDW-SD/Alb)是否可作为APE的有用预后标志物,并提高sPESI的预测能力。
本研究为单中心回顾性分析,纳入年龄超过18岁的患者。我们连续纳入235例确诊为APE的住院患者。为了评估RDW-SD/Alb、sPESI以及联合使用sPESI加RDW-SD/Alb预测6个月全因死亡的敏感性和特异性,我们使用了受试者工作特征(ROC)曲线。此外,我们进行了Kaplan-Meier分析,以评估RDW-SD/Alb水平升高(>13.6)对患者生存时间的影响。我们使用多变量Cox回归分析来确定影响患者生存的独立预后因素。
RDW-SD/Alb>13.6组的死亡率显著高于RDW-SD/Alb≤13.6组。sPESI加RDW-SD/Alb的ROC曲线下面积(AUROC)在统计学上大于sPESI的AUROC(p = 0.025)。在完全调整模型中,RDW-SD/Alb水平升高与入院后6个月内的全因死亡率始终相关。
当纳入RDW-SD/Alb>13.6参数时,sPESI对6个月全因死亡的预测价值有所提高。RDW-SD/Alb是一种新型炎症标志物,是预测APE患者6个月全因死亡率的独立预后因素。